Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer
Clinical trial NCT01111591 · UNKNOWN
Trial details
- NCT number
- NCT01111591
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2017-06-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.